⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12989533 | 0.77 | — | — | |
| SCHEMBL13301137 | 0.75 | — | — | |
| SCHEMBL11261713 | 0.75 | CRBN (0.36) | — | |
| SCHEMBL8831148 | 0.75 | CTSD (0.38) | — | |
| SCHEMBL7594795 | 0.74 | — | — | |
| SCHEMBL14110253 | 0.73 | MCL1 (0.41) | — | |
| SCHEMBL17031999 | 0.73 | MEN1 (0.33) | — | |
| SCHEMBL8762036 | 0.73 | HDAC3 (0.38) | — | |
| SCHEMBL18101912 | 0.73 | HDAC3 (0.38) | — | |
| SCHEMBL6323330 | 0.73 | ALDH1A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5688828-A | TREATMENT OF VISION DEFECTS | ALCON LABORATORIES, INC. (US) | 1997-11-18 | — | — | US | claimed |
| US-5688828-A | TREATMENT OF VISION DEFECTS | ALCON LABORATORIES, INC. (US) | 1997-11-18 | — | — | US | disclosed |
| US-5686450-A | Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents | ALCON LABORATORIES, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| US-5218112-A | Linking agents and methods | XOMA CORPORATION (US) | 1993-06-08 | — | — | US | disclosed |
| US-4970303-A | Linking agents and methods | XOMA CORPORATION (US) | 1990-11-13 | — | — | US | disclosed |
| EP-0326863-A2 | Linking agents and methods | Xoma Corporation (US) | 1989-08-09 | — | — | EP | disclosed |